Disbandment. The JDC shall remain in effect from the date on which it is established in accordance with Section 3.1 until, on a Research Program-by-Research Program basis, the expiration of the applicable Research Term.
Appears in 5 contracts
Sources: Antibody Discovery and Option Agreement (Galecto, Inc.), Adc Discovery and Option Agreement (Glycomimetics Inc), Antibody Discovery and Option Agreement (Aerovate Therapeutics, Inc.)
Disbandment. The JDC shall remain in effect from the date on which it is established in accordance with Section 3.1 until, on a Research Program-by-Research Program basis, the earlier of (a) expiration of the applicable Research TermTerm and (b) Spyre’s exercise of the Option in accordance with Section 4.3.
Appears in 2 contracts
Sources: Antibody Discovery and Option Agreement (Spyre Therapeutics, Inc.), Antibody Discovery and Option Agreement (Aeglea BioTherapeutics, Inc.)
Disbandment. The JDC shall remain in effect from the date on which it is established in accordance with Section 3.1 3.1 until, on a Research Program-by-Research Program basis, the earlier of (a) expiration of the applicable Research TermTerm and (b) Spyre’s exercise of the Option in accordance with Section 4.3.
Appears in 1 contract
Sources: Antibody Discovery and Option Agreement (Aeglea BioTherapeutics, Inc.)
Disbandment. The JDC shall remain in effect from the date on which it is established in accordance with Section 3.1 until, on a Research Program-by-Research Program basis, until the expiration of the applicable Research Term.
Appears in 1 contract
Sources: Adc Discovery and Option Agreement (Glycomimetics Inc)
Disbandment. The JDC shall remain in effect from the date on which it is established in accordance with Section 3.1 until, on a Research Program-by-Research Program basis, the earlier of (a) expiration of the applicable Research TermTerm and (b) Apogee’s exercise of the Option in accordance with Section 4.3.
Appears in 1 contract
Sources: Antibody Discovery and Option Agreement (Apogee Therapeutics, Inc.)
Disbandment. The JDC shall remain in effect from the date on which it is established in accordance with Section 3.1 3.1 until, on a Research Program-by-Research Program basis, the expiration of the applicable Research Term.
Appears in 1 contract
Sources: Antibody Discovery and Option Agreement (ARCA Biopharma, Inc.)